Introduction
At some point, most peptide researchers need a compound that is not available from catalog stock — a novel sequence for structure-activity studies, a modified analog for pharmacokinetic optimization, a labeled peptide for imaging, or a specific fragment of a protein of interest. Custom peptide synthesis services can produce virtually any sequence from 2 to approximately 100 amino acids, with a wide range of modifications, at scales from micrograms to grams. However, getting the right peptide at the right quality for the right price requires informed decisions about specification, purity, scale, and supplier selection.[1][2]
This article provides practical guidance for researchers navigating the custom synthesis process. For the underlying chemistry, see our articles on solid-phase peptide synthesis (SPPS) and peptide purification methods. For the broader manufacturing context, see our peptide synthesis and manufacturing guide.
Specifying Your Sequence Correctly
Sequence Format
Peptide sequences should be communicated using standard amino acid notation — either the one-letter code (e.g., YLRIVQCRSVEGSCGF for AOD-9604) or the three-letter code (e.g., Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe). The three-letter code is preferred for orders because it is less prone to transcription errors and unambiguously specifies each residue. Sequences are written from N-terminus (left) to C-terminus (right) by convention — the same direction as biological translation, but the opposite of the synthesis direction in SPPS.[1]
Terminal Modifications
The N-terminus and C-terminus of a synthetic peptide can be left as free amine (H-) and free acid (-OH) respectively, or modified. The most common terminal modifications are N-terminal acetylation (Ac-) and C-terminal amidation (-NH2), which cap the terminal charges and more closely mimic the peptide as it would exist within a larger protein sequence. C-terminal amidation also improves resistance to carboxypeptidase degradation and can enhance biological activity for some sequences. If no terminal modifications are specified, most suppliers will deliver the peptide with free termini. Researchers should explicitly state their terminal requirements, as the choice affects biological activity, stability, and chromatographic behavior.[1][2]
Disulfide Bonds and Cyclization
If the target peptide contains cysteine residues that should form a disulfide bond (as in AOD-9604, oxytocin, or many antimicrobial peptides), this must be explicitly specified. The supplier needs to know which cysteines should be paired and whether the peptide should be delivered in the oxidized (disulfide-bonded) or reduced (free thiol) form. For peptides with multiple disulfide bonds, the specific pairing pattern must be defined. Disulfide bond formation is a post-synthetic step that adds complexity and cost. For more on disulfide chemistry, see our article on peptide modifications and conjugates.[2]
Selecting the Right Purity Grade
Purity selection is one of the most important decisions in a custom peptide order, directly affecting both cost and suitability for the intended application.[1][2]
Crude or desalted peptide (no HPLC purification, typically 50-80% purity) is appropriate for antibody production and initial screening in large libraries where cost per peptide must be minimized. Standard purity (≥95% by HPLC) is the minimum recommended grade for most biological assays, including ELISA, cell-based assays, binding studies, and general research use — providing a reliable balance between purity, yield, and cost. High purity (≥98%) is recommended for quantitative studies (dose-response curves, IC50 determinations), in vivo experiments, structural studies (NMR, crystallography), and any application where impurity interference could compromise data. Ultra-high purity (≥99%) is required for clinical and GMP-regulated applications.[2]
Over-specifying purity wastes money without improving experimental outcomes — a ≥99% peptide used for ELISA coating offers no practical advantage over ≥95%. Under-specifying purity risks confounded results — using a crude peptide for quantitative binding studies means the effective concentration of active peptide is unknown, potentially invalidating concentration-dependent measurements.
Understanding Cost Drivers
Sequence Length
Length is the single largest cost determinant. Each amino acid added requires an additional synthesis cycle, consumes additional building blocks and coupling reagents, and reduces the cumulative yield of the correct full-length product. A 10-amino-acid peptide is straightforward and inexpensive; a 40-amino-acid peptide is substantially more challenging; sequences beyond 50 amino acids approach the practical limits of single-chain SPPS and may require fragment condensation or native chemical ligation, which further increase cost.[1][2]
Amino Acid Composition
Not all amino acids are equally easy to incorporate. Sequences rich in sterically hindered residues (isoleucine, valine) couple more slowly and may require double coupling. Consecutive runs of the same residue (polyalanine, polyglutamine) are prone to on-resin aggregation. Arginine residues require expensive Pbf-protected building blocks. Non-natural amino acids, D-amino acids, and isotopically labeled residues are substantially more expensive and may not be compatible with standard automated protocols.[2]
Modifications
Post-synthetic modifications increase cost proportionally to their complexity. Simple modifications like N-terminal acetylation add minimal cost. Disulfide bond formation adds a moderate premium. Biotinylation, fluorescent labeling, fatty acid conjugation (lipidation), and PEGylation range from moderate to expensive depending on the specific chemistry. Complex modifications like those found on therapeutic peptides — the C-18 fatty diacid on GLP-1 agonist peptide or the C-20 chain on GLP dual agonist peptide — require highly specialized synthesis. See our article on peptide modifications and conjugates.[2]
Scale and Purity
Larger scales are more cost-effective per milligram because fixed setup costs are amortized over more product. Higher purity requirements reduce yield from a given crude batch, increasing per-milligram cost. Researchers should order the minimum quantity needed plus a reasonable surplus, at the minimum purity grade that satisfies their application requirements.
Evaluating Suppliers
The research peptide market includes a wide range of suppliers. Key evaluation criteria include the following.[2]
Analytical documentation is the most important quality indicator. Every custom peptide should be delivered with a Certificate of Analysis (CoA) including analytical HPLC purity data (chromatogram, not just a number), mass spectrometry confirmation of molecular weight (spectrum showing observed mass matching theoretical), and product appearance description. The absence of any of these elements should be considered a disqualifying deficiency. Third-party testing by an independent laboratory provides the highest quality assurance.
Technical capability matters for complex orders. Not all suppliers can handle long sequences (above 40 amino acids), difficult compositions, or specialized modifications. Researchers should verify specific experience with their order type. Communication responsiveness during quoting is often predictive of support quality if problems arise.
Common Specification Mistakes
Several errors commonly arise when researchers order custom peptides. Ambiguous termini — failing to specify N-terminal and C-terminal modifications — can result in a peptide that behaves differently than expected. Counterion assumptions — assuming the peptide will be delivered as the acetate salt when TFA salt is the default — can affect TFA-sensitive cell-based assays. Ignoring peptide content — the mass of lyophilized peptide includes water, counterions, and residual salts; actual peptide content may be 60-80% of total mass, meaning 1 mg of powder contains only 0.6-0.8 mg of actual peptide. For quantitative applications, peptide content must be accounted for when preparing stock solutions.
Sequence errors are surprisingly common — transposed residues, missing terminal amino acids, or confusion between similar amino acids (Leu/Ile, Asp/Asn, Glu/Gln) can produce a chemically correct but biologically inactive peptide. Double-checking the sequence against published literature or protein databases before submission is essential.
Catalog vs Custom: When Each Makes Sense
Many commonly studied peptides — including BPC-157, TB-500, GHK-Cu, and AOD-9604 — are available as catalog products. Catalog peptides are typically less expensive because synthesis has been optimized for that specific sequence, production is done in larger batches, and quality control protocols are established.
Custom synthesis is necessary when the specific sequence is not commercially available, when particular modifications or labeling are required, when non-standard purity or scale is needed, or when the peptide is a novel design. For standard research peptides available from catalog, the additional cost of custom synthesis is rarely justified unless the researcher needs a specification that no catalog product meets.
What to Expect in Your Delivery
A properly documented custom peptide delivery should include the lyophilized peptide in a sealed vial (typically amber glass, under nitrogen), a Certificate of Analysis with HPLC chromatogram and mass spectrum, the net peptide content or total mass, and the lot number for traceability. The peptide should appear as a white to off-white powder or fluffy cake. Any discoloration, excessive clumping, or visible crystalline material warrants contacting the supplier before use. For guidance on handling, see our articles on lyophilized peptides, peptide reconstitution, and peptide stability.
Summary
Ordering custom-synthesized peptides requires informed decisions across several dimensions: sequence specification (correct notation, explicit terminal modifications, disulfide bond instructions), purity grade selection (matched to the intended application), understanding cost drivers (length, composition, modifications, scale, and purity), supplier evaluation (analytical documentation quality is the primary reliability indicator), and avoiding common mistakes (ambiguous termini, counterion assumptions, peptide content versus total mass, sequence verification). When these decisions are made thoughtfully, custom peptide synthesis provides researchers with precisely the molecular tools they need for their experimental objectives.
